论文部分内容阅读
目的本次研究主要分析在妇科内分泌疾病中,芳香化酶抑制剂的使用效果。方法以本院2014年6月至2016年9月所接收的妇科内分泌患者98例为研究对象,将这98例研究对象随机的分为研究组、对照组,各49例。其中对照组患者使用米非司酮进行治疗,研究组患者使用芳香化酶抑制剂进行治疗,观察并对比两组患者的治疗效果。结果研究组、对照组患者在接受治疗之后,在治疗有效率方面,研究组患者明显要高于对照组,差异有统计学意义(P<0.05);此外,在不良反应方面,研究组患者出现的不良反应率明显要低于对照组,差异有统计学意义(P<0.05)。结论根据研究结果表明,芳香化酶抑制剂在治疗妇科内分泌疾病上,其治疗效果显著,且安全性高,具有临床意义,值得推广使用。
Purpose This study focused on the use of aromatase inhibitors in gynecological endocrine disorders. Methods A total of 98 cases of gynecological endocrine patients received from June 2014 to September 2016 in our hospital were selected as research objects. The 98 subjects were randomly divided into study group and control group, with 49 cases in each group. The patients in the control group were treated with mifepristone. The patients in the study group were treated with aromatase inhibitors. The therapeutic effect was observed and compared between the two groups. Results After treatment, the patients in study group and control group were significantly higher in treatment efficiency than in control group, with significant difference (P <0.05). In addition, patients in study group appeared adverse reactions The adverse reaction rate was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusions According to the results of the study, the aromatase inhibitor has significant therapeutic effect on gynecological endocrine diseases with high safety and clinical significance, which is worth promoting.